In the treatment of chronic airflow obstruction in ambulatory patients who are not in acute respiratory failure, the use of intermittent positive pressure breathing (IPPB) is often advocated. Improvement of arterial blood gases during and between treatments has been reported (Hickam, 1963; Daly and Duff, 1963) . Some authors have reported a lack of decrease of arterial CO2 (Kamat, Dulfano, and Segal, 1962; Sukumalchantra, Park, and Williams, 1965) . The effect of IPPB on cardiac output has been studied (Cournand, Motley, Werko, and Richards, 1948; Cathcart, Fraimow, Nealon, and Price, 1960; Andersen and Kuchiba, 1967) and the cardiac output has been found to be decreased in many instances, particularly with high mask pressures, with an excessively long inspiratory phase, and when cardiac output is already lower than normal.
The purpose of this study was to compare patients with chronic expiratory airflow obstruction and controls before, during, and after IPPB with 40% oxygen (IPPB/02), observing in particular the changes in cardiac output and the changes in arterial carbon dioxide (Paco). mEcrs Sixteen men were studied. There were eight patients with lung disease. Seven of them were diagnosed as having chronic expiratory airflow obstruction on the basis of symptoms and clinical data. In Table I are reported the diagnoses of asthma, chronic bronchitis, and emphysema as applicable to each patient (patients 1 to 7).
Patient 9 had no symptoms of airflow obstruction. A chest radiograph done before abdominal surgery revealed a pneumatocoele but no evidence of generalized lung disease.
The spirometric tests (Table I) show that the vital capacity in the eight patients with lung disease ranged between 72 and 37% of predicted; the maximum voluntary ventilation (MVV) ranged between 42 and 14% of predicted; the forced expiratory volume in one second (FEV1.0) ranged between 54 and 23% of the forced expiratory vital capacity (FEVC). Therefore, by spirometry, they mostly had obstructive, rather than restrictive, reduction in the FEV.
The residual volume to total lung capacity ratio (R/T) ranged from 51 to 72%. Distribution of ventilation was slightly to greatly abnormal, as shown by the A CO2 test (Tulou, 1966 (RISA) were injected rapidly into an antecubital vein. Radioactivity was monitored with a scintillation detector1 aiming at the arch of the aorta through the medial end of the second left intercostal space.
For each measurement of cardiac output a record of radioactivity and the blood volume known from the dilution of RISA gave the necessary data for measurement of cardiac output (Hamilton, 1962; Guyton, 1963 is necessary to achieve this, and we had to discard five cases from an original total of 21 because it was felt that a change of position had occurred.
We have accepted the serum albumin method as valid for measuring cardiac output, and have not ourselves assessed the limits of error. Griinert, Oeff, and Schmidt (1963) compared praecordial isotope dilution zurves and arterial dilution curves in rabbits, while Zekert, Herbig, and Cooper (1966) compared praecordial isotope dilution curves and indocyanine green dilution curves in man.
MEASUREMENTS OF OTHER VARIABLES With each of the three cardiac output determinations, arterial blood was collected through an indwelling arterial needle in the brachial artery; the pulse rate, breathing rate, blood pressure (by sphygmomanometer), and electrocardiogram were recorded. Arterial blood analysis was done by the Astrup method (Andersen, Engel, J0rgensen, and Astrup, 1960; Andersen and Engel, 1960 case it increased greatly. Paco2 decreased greatly in all subjects except in one in whom it remained basically unchanged. Changes in cardiac output and PaCO2 from rest to IPPB/02 appeared to be the most important variables to study, and a scattergram was obtained by plotting per cent change in cardiac output against per cent change in PaCO2 (Figure) . Clearly, the controls and patients form two different populations. A big decrease in cardiac output and a Paco2 unchanged or moderately diminished characterize the patients, except for case 9. In controls, PaCO2 decreased greatly; cardiac output was lowered much less than in the patients.
As noted under 'Methods', case 9 was considered a patient with lung disease on the basis of radiological evidence of a pneumatocoele; but he did not have symptoms of respiratory obstruction. We calculated mean values in the patients after eliminating case 9 and compared those with the mean values in the controls (Table III) Since the pulse rate had not changed, there was a decrease of stroke volume. Arterial Pco2 had slightly increased to 53 (+6%). In Fig. 1 Case 7 showed this lack of decrease of Paco2 despite the decrease in cardiac output. CASE 13 Between the extremes just described was a 28-year-old laboratory technician with normal function tests. Cardiac output was 6-93, pulse rate 78, stroke volume 89. On IPPB/02, Paco2 decreased from 37 to 31, cardiac output from 6-93 to 567. In the Figure he lay quite close to the cluster of patients, but his stroke volume had iinereased by 7%. In a scattergram where change in Paco2 was plotted against change in stroke volume, he was better separated from the patient group. CASE 16 Of the subjects without respiratory obstruction, this one had the greatest decrease in cardiac output as well as stroke volume during IPPB/02. He was a 72-year-old man with a normal VC (109% of predicted). The low MVV (51% of predicted) and a residual volume of 2-7 1. would be compatible with chronic airflow obstruction, but the symptoms of this condition were not present, and Paco2 decreased as in the other controls (-31%).
CASE 9 This patient behaved quite differently from the others. We considered him to have lung disease because he had a pneumatocoele on the chest radiographs and functional signs of airway obstruction (MVV 34%, FEVro 47%). But he had no history or symptoms of chronic bronchitis and/or emphysema and no radiographic evidence of diffuse emphysema. His decrease in PaCo2 during IPPB/02 (-31%) with no decrease in cardiac output (+9%) suggested that the factors which prevent alveolar hyperventilation and decrease cardiac output in patients with respiratory obstruction did not exist in this case of pneumatocoele.
DISCUSSION
The patients with chronic airflow obstruction did not show abnormally large cardiac output, such as were reported by Harvey, Ferrer, Richards, and Cournand (1951) . In this series, the four lowest values were observed in patients with expiratory airflow obstruction. Hypovolaemia was ruled out as a possible cause of low cardiac output by normal blood volume determinations.
The rapid pulse at rest (108 on the average) is a well-known occurrence in patients with advanced chronic bronchitis and emphysema. It has been suggested that a powerful sympathetic drive exists at rest in such patients and is partly reversible by /8-adrenergic blockade, as shown by Lockhart, Schrijen, Salmon, Andrada, and Peslin (1967) . In our patients the heart rate decreased only 40,< during IPPB/02, and the decrease in cardiac output was related to a decrease in stroke volume (-21 of')-If Paco2 decrease can be considered an index of increase in effective ventilation, this failed remarkably to happen in these patients with airflow obstruction. Anatomical and mechanical alterations of the lung with chronic airflow obstruction, failure to cooperate with the ventilator, and reflex mechanisms (Guyton, 1963 ) can be thought of as possible reasons. The decrease in cardiac output and stroke volume can be explained by a reduction in venous return, or by interference with alveolar capillary blood flow (Andersen and Kuchiba, 1967) or by a combination of these two mechanisms brought about by increased intrathoracic pressure. It seems noteworthy that the above changes were observed with rather modest positive pressures.
The data in the Figure suggest that if IPPB/02
had lowered the Paco2 in the patients to the same extent as in the controls, the fall in cardiac output would have been extremely large. IPPB was given with oxygen at a concentration supposed to be 40%. Recent experience has demonstrated to us that the IPPB machine may deliver a higher concentration than it is supposed to deliver. A comparison of IPPB/02 and IPPB/ air is underway in our laboratory and will be the subject of a later communication. In the present study, Pao2 values are reported in Table II , and there is no reason to believe that the different responses of patients and controls were due to different concentrations of inspired oxygen. One should keep in mind that°2 breathing at ambient pressure depresses cardiac output in normals and patients (Cotes, Pisa, and Thomas, 1963) .
One factor which may explain the lack of effect of IPPB on Paco2 is the inequality of distribution of ventilation to different areas of the lungs, a well-known pathophysiological feature of some patients with chronic airflow obstruction caused by bronchitis in particular. While some authors found an improvement of this abnormality during IPPB (Torres, Lyons, and Emerson, 1960) , other authors consider that the positive pressure distributes itself preferentially to already well-ventilated areas of the lungs (Jones, Macnamara, and Gaensler, 1960; Sukumalchantra et al.. 1965) .
POST IPPB MEASUREMENT In some subjects the lack of return of cardiac output to previous values could cause some concern. In case 3, the pre IPPB D value was less than 40 1./min and dropped to 2-72 1./min during IPPB/02. Thirty minutes post IPPB/02 it was still only 2-86 1./minute. These low values could have adverse effects if sustained or repeated. It is interesting to note that this patient experienced no subjective improvement from IPPB treatments.
IPPB machines give the possibility of using higher pressures than were used in this study. In all probability, higher pressures, and longer periods of treatment, could result in more adverse effects than we have observed.
It is evident that a great number of factors influence the effect of IPPB/02 on cardiac output and Paco2. In this study we have attempted to keep constant as many variables as possible. We have learned that, in the same conditions of positive pressure breathing, the lung with chronic expiratory airflow obstruction is not ventilated as well as the normal lung.
Whenever IPPB/02 is considered in the treatment of the ambulatory patient with airflow obstruction who is not in acute failure, it should be remembered that an initially low cardiac output may be decreased even more, and an improvement in alveolar ventilation or existing hypercapnia is not to be expected.
Whenever possible, direct measurement of the changes in Paco2 and cardiac output during IPPB/02 should be obtained.
